FRANKFURT Oct 5 Stada, the German generic drugmaker whose chairman was ousted by disgruntled investors, said it was banking on branded products to underpin longer term growth.
The company said on Wednesday that its target of group sales of 5 percent on average per year until 2019 would be driven by 8 percent growth per year at the branded products business, which makes brand-name prescription drugs that have lost patent protection as well as branded non-prescription drugs...
23:35 Mexico's 'El Chapo': From Selling Candy To Selling Drugs11
15:02 U.S housing starts surge in December; jobless claims near 43-year low13
03:35 Ivan Rodriguez, Tim Raines and Jeff Bagwell prove Hall of Fame does forgive17
23:10 Tim Raines, Jeff Bagwell, Pudge Rodriguez elected to Baseball Hall of Fame18